Delivery Order V797D70052-15B10224F00000096
Award Date
7/8/24
Potential Completion Date
1/31/25
Potential Value
Not listed
Federal Agency
Federal Correctional Institution Ashland
Awardee
Emergent Devices, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
Q517 - Pharmacy Services
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
PLYMOUTH MTNG, PA 19462, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed price delivery order awarded by the Department of Justice Bureau of Prisons Federal Correctional Institution Ashland to Emergent Devices, Inc. (also known as Emergent BioSolutions), a for-profit manufacturer, for the supply of NARCAN (naloxone nasal spray). The order, valued at $1,356.84, is being awarded under Emergent Devices' Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB) and has an expected completion date of October 31, 2024. This contract...
This is a delivery order awarded by the Indian Health Service, a civilian agency within the U.S. Department of Health and Human Services, to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, for a $417,820.68 firm fixed-price contract to provide a stock of NARCAN (naloxone) to the National Supply Service Center (NSSC) warehouse customers. The contract has no set-aside designation and is part of Emergent Devices' existing $11.8 million multiple-award Federal Supply Schedule...
This is a $455,898.24 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Emergent Devices, Inc., a pharmaceutical manufacturer, for the supply of NARCAN nasal spray, a naloxone product used to rapidly reverse opioid overdoses. The contract has an ultimate completion date of August 17, 2016 and was awarded on August 10, 2016 without any set-aside designation. Emergent Devices, a subsidiary of Emergent BioSolutions, is a key supplier of naloxone...
The U.S. Immigration and Customs Enforcement (ICE) awarded a Firm Fixed Price Delivery Order to Emergent Devices, Inc., a manufacturer of pharmaceutical products, for the provision of NARCAN (naloxone nasal spray) with a potential value of $101,310.72. The order was placed under Emergent Devices' Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). NARCAN is an emergency medication used to rapidly reverse opioid overdoses. Emergent Devices has previously received...
This is a delivery order contract awarded by the Federal Emergency Management Agency (FEMA) to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, to purchase NARCAN nasal spray in support of FEMA's Environmental, Safety & Health Division operations. The contract has a firm fixed price of $15,921.60 and a completion date of May 31, 2024. Emergent Devices holds multiple federal contracts and grant sub-awards to supply naloxone products, including NARCAN, to various government...
This is a delivery order awarded by the Federal Emergency Management Agency (FEMA) to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, for the purchase of NARCAN nasal spray in support of FEMA's Environmental, Safety & Health Division operations. The award is for a Firm Fixed Price contract with a ceiling value of $18,995.76 and a completion date of June 1, 2024. Emergent Devices is a subsidiary of Emergent BioSolutions and is a key supplier of naloxone products to various...
This is a federal delivery order awarded by the Department of Health and Human Services Indian Health Service to Emergent Devices, Inc., a for-profit manufacturer of pharmaceutical products. The $178,164.00 contract is for the purchase of NARCAN nasal spray, a medication that rapidly reverses opioid overdoses. This delivery order is placed against Emergent Devices' Federal Supply Schedule (FSS-61-IB) contract for pharmaceuticals and drugs. No set-aside designation was used. Emergent Devices...
The Department of Homeland Security's Customs and Border Protection awarded Emergent Devices, Inc., a for-profit manufacturer, a $152,712 firm-fixed-price delivery order contract for NARCAN, a naloxone nasal spray used to rapidly reverse opioid overdoses. This order was placed against Emergent Devices' Federal Supply Schedule 65 IB contract for pharmaceutical and hematology products, which runs through August 2028. Emergent Devices has previously provided NARCAN to other federal agencies,...
The Department of Veterans Affairs Veterans Health Administration awarded a $904,465.44 firm fixed price delivery order to Emergent Devices, Inc. for the provision of naloxone nasal spray. Naloxone is a medication that rapidly reverses opioid overdoses and treats substance abuse. Emergent Devices, a for-profit manufacturer, holds a Federal Supply Schedule 65 IB contract to provide pharmaceuticals and drugs to VA facilities through 2028. This delivery order was placed against that larger contract...
The Department of Homeland Security Customs and Border Protection awarded a firm-fixed-price delivery order to Emergent Devices, Inc., a for-profit manufacturer, for the provision of naloxone/NARCAN nasal spray. The $150,465.60 contract has an August 2019 completion date and is not set aside. Emergent Devices holds a Federal Supply Schedule pharmaceutical contract with the Department of Veterans Affairs and has also received federal grant sub-awards to support naloxone distribution efforts. This...